Table 4.
Author | Age | Gender | Cancer | Liver metastasis | Drug | Time to tumor lysis syndrome | Rasburicase | Outcome |
---|---|---|---|---|---|---|---|---|
Brunnhoelzl and Wang 10 | 77 | F | Renal urothelial | Yes | Atezolizumab | Day 14 | No | Death |
Herbst et al14 | 70 | N/A | Renal urothelial | N/A | Atezolizumab | N/A | N/A | N/A |
Sater HA et al15 | 74 | M | Renal cell carcinoma | No | Nivolumab | Day 2 | N/A | Death |
Our case report | 37 | F | Renal cell carcinoma | Yes | Pembrolizumab | Day 8 | No | Death |